No Data
Gilead Sciences - B [01672] is currently reported at 4.4 Hong Kong dollars, with an increase of 11.68%.
As of 09:30, Gilead Sciences - B [01672] is reported at 4.4 HKD, up 0.46 HKD or 11.68% from yesterday's closing price of 3.94 HKD, with a transaction volume of 1.7515 million HKD. Today's highest price is 4.4 HKD, and the lowest price is 4.15 HKD. Based on yesterday's closing price, the 10-day average price is 3.40 HKD, and the 50-day average price is 2.40 HKD, with a current PE of -26.53 times, and a 14-day Relative Strength Index of 66.20.
Express News | Ascletis Pharma Inc - Asc30 Shows Dose-Proportional Pk Properties and Long Half-Life up to 60 Hours
Express News | Ascletis Announces Positive Results From U.S. Phase Ia Single Ascending Dose Study of Small Molecule Oral Glp-1R Agonist Asc30 and Provides Program Update
ASCLETIS-B (01672.HK): Small molecule oral GLP-1R agonist ASC30 has achieved positive results in the USA Phase Ia single-dose escalation study.
Gelonghui reported on January 21 that ASCLETIS-B (01672.HK) announced that in a single ascending dose (SAD) study conducted on obese patients, ASC30 oral tablets demonstrated dose-proportional pharmacokinetic (PK) characteristics, with a half-life (t1/2) of up to 60 hours, supporting once-daily or lower frequency oral administration. The overall safety and tolerance of ASC30 oral tablets were good. All adverse events (AEs) were mild (Grade 1) or moderate (Grade 2), with most AEs related to gastrointestinal (GI) issues. No Grade 3 or...
Insiders of Ascletis Pharma Inc. (HKG:1672) Were Rewarded After Last Week's 19% Gain
On January 16, ASCLETIS-B (01672.HK) spent 0.026 million Hong Kong dollars to repurchase 8,000 shares.
Gelonghui, January 16丨ASCLETIS-B (01672.HK) announced that on January 16, it spent 0.026 million Hong Kong dollars to buy back 8,000 shares.
